2型糖尿病患者心力衰竭预后模型:系统综述与荟萃分析
RECODe、TRS-HFDM和WATCH-DM表现出最佳性能,QDiabetes-HF区分度良好但仅外部验证一次。四个模型有望用于临床实践。
要点
- RECODe模型区分度C-statistic=0.75(95%CI 0.72-0.78),证据确定性高。
- TRS-HFDM模型C-statistic=0.75(95%CI 0.69-0.81),证据确定性低。
- WATCH-DM模型C-statistic=0.70(95%CI 0.67-0.73),证据确定性中等。
核心结论
- 在已识别的预后模型中,四个模型表现出有前景的性能,可考虑在当前临床实践中实施。
研究设计与样本
- 系统综述与荟萃分析,检索Medline、Embase、CENTRAL、Cochrane系统综述数据库和Scopus(从建库至2022年7月)及灰色文献。
- 对有多项验证研究的模型采用随机效应荟萃分析合并区分度,并对校准进行描述性综合,评估偏倚风险和证据确定性(高、中、低)。
主要发现
- RECODe的C-statistic=0.75(95%CI 0.72-0.78),95%预测区间(PI)为0.68-0.81,证据确定性高。
- TRS-HFDM的C-statistic=0.75(95%CI 0.69-0.81),95%PI为0.58-0.87,证据确定性低。
- WATCH-DM的C-statistic=0.70(95%CI 0.67-0.73),95%PI为0.63-0.76,证据确定性中等。
- QDiabetes-HF也表现出良好区分度,但仅被外部验证一次,未进行荟萃分析。
临床怎么用
- RECODe、TRS-HFDM、WATCH-DM和QDiabetes-HF四个模型在2型糖尿病患者中预测心力衰竭表现出良好区分度,可考虑用于临床风险分层。
局限性
- TRS-HFDM的证据确定性低,WATCH-DM为中等,RECODe为高。
- QDiabetes-HF仅外部验证一次,未纳入荟萃分析。
- 校准数据仅进行描述性综合,未量化合并。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide a systematic review, critical appraisal, assessment of performance and generalisability of all the reported prognostic models for heart failure (HF) in patients with type 2 diabetes (T2D). METHODS: We performed a literature search in Medline, Embase, Central Register of Controlled Trials, Cochrane Database of Systematic Reviews and Scopus (from inception to July 2022) and grey literature to identify any study developing and/or validating models predicting HF applicable to patients with T2D. We extracted data on study characteristics, modelling methods and measures of performance, and we performed a random-effects meta-analysis to pool discrimination in models with multiple validation studies. We also performed a descriptive synthesis of calibration and we assessed the risk of bias and certainty of evidence (high, moderate, low). RESULTS: Fifty-five studies reporting on 58 models were identified: (1) models developed in patients with T2D for HF prediction (n=43), (2) models predicting HF developed in non-diabetic cohorts and externally validated in patients with T2D (n=3), and (3) models originally predicting a different outcome and externally validated for HF (n=12). RECODe (C-statistic=0.75 95% CI (0.72, 0.78), 95% prediction interval (PI) (0.68, 0.81); high certainty), TRS-HFDM (C-statistic=0.75 95% CI (0.69, 0.81), 95% PI (0.58, 0.87); low certainty) and WATCH-DM (C-statistic=0.70 95% CI (0.67, 0.73), 95% PI (0.63, 0.76); moderate certainty) showed the best performance. QDiabetes-HF demonstrated also good discrimination but was externally validated only once and not meta-analysed. CONCLUSIONS: Among the prognostic models identified, four models showed promising performance and, thus, could be implemented in current clinical practice.
引用
- Kostopoulos, Doundoulakis, Toulis, et al. Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis. Heart. 2023. PMID: 36898704. doi:10.1136/heartjnl-2022-322044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。